Impact board meeting meaning

Set out as a Q&A, the paper aims to guide medical device makers and healthcare professionals on how the EU AI Act’s obligations align with those in Regulation (EU) 2017/745 (the Medical Devices Regulation) and Regulation (EU) 2017/746 (the In Vitro Diagnostic Medical Devices Regulation) (together, the Medical Device Regulations (MDRs)). An initial draft, seen by MLex, will be discussed at a meeting of a specialist subgroup of the European AI Board—an EU forum of national authorities—on 3 March 2025, with a final text potentially put to the board for approval in June 2025. Under the EU AI Act, where an AI system forms a product or a safety component of a product that requires third-party conformity assessment under sectoral law, it is classified as ‘high-risk’ and must observe a notably strict due diligence framework. This guidance is a first move to tackle that regulatory overlap and may flag early where frictions could arise between the EU AI Act and this category of sectoral legislation. It is intended for manufacturers...

ARCHIVED: This Practice Note has been archived and is not maintained. It distils key legal developments relevant to personal injury and clinical negligence practitioners as at 30 October 2023. For matters predating this horizon scanner, see PI and Clinical Negligence horizon scanning—overview. Key PI & Clinical negligence developments Minutes from Official Injury Claim Advisory Group’s 19 July 2023 meeting published The Ministry of Justice (MoJ) has released the minutes of the Official Injury Claim (OIC) Advisory Group meeting held on 19 July 2023. Attendees were: Chair and Secretariat from the MoJ OIC service operators from the Motor Insurers’ Bureau (MIB) Association of Personal Injury Lawyers (APIL) Motor Accident Solicitors Society (MASS) Forum of Insurance Lawyers (FOIL) Association of British Insurers (ABI) HM Courts and Tribunals Service (HMCTS) During the meeting, the MIB summarised the latest OIC data, described work on filtering dormant claims, and delivered updates based on user and member feedback. Agreed...

This archived Practice Note examined the principal issues for Corporate practitioners arising from the coronavirus (COVID-19) pandemic. It has not been revised since May 2022. General meetings and AGMs The coronavirus outbreak created immediate legal and practical challenges for companies intending to hold their annual general meeting (AGM) or other general meetings. For more information, see Practice Note: Coronavirus (COVID-19)—holding general meetings and AGMs. Latest guidance for company meetings in 2021 Chartered Governance Institute guidance for company meetings in 2021 On 24 February 2021, the Chartered Governance Institute (CGI) issued updated guidance (the 2021 Guidance), anticipating that general meetings would need to be conducted on a closed basis until at least 17 May 2021, and potentially until at least 21 June, due to the government’s ‘stay at home measures’. The 2021 Guidance was produced by a working group comprising the City of London Law Society Company Law Committee and Martin Moore QC With the support of the Department for Business, Energy...

ARCHIVED: This archived Practice Note sets out key dispute resolution (DR) appeals or notable appellate court rulings in the sphere of general civil litigation in England and Wales from 2023 to the present, and highlights significant pending appeal matters (to support horizon scanning) alongside reported decisions handed down by the Supreme Court, Court of Appeal, Competition Appeal Tribunal, Judicial Committee of the Privy Council (the Privy Council), Court of Justice of the European Union (Court of Justice) and the European Court of Human Rights (ECtHR). Links are provided to each judgment and any bespoke News Analysis to aid comprehension of the principles addressed in the decisions and the impact of those rulings. This Practice Note comprises two elements designed to help dispute resolution practitioners stay current with developments in case law that affect their practice area, or that bear upon civil litigation procedure more generally: selected forthcoming appeals to the Supreme Court are listed below; see Dispute resolution: key appeal cases—2023—Key forthcoming appeals to the Supreme...

Company No: [ insert number ] [ Insert company name ] PLC Minutes from a meeting of [ a committee of ] the board of directors (the Meeting) of [ insert full name of company ] plc (the Company) Convened at [ insert place of meeting ] On [ insert day, month and year of meeting ] at [ insert time of meeting ] [ am OR pm ] Present [ Insert the names of the director(s) in physical attendance ] [ Insert the names of any directors attending by remote means (except where such means are specifically disallowed by the Company’s articles of association) (via [ insert mode of attendance for each director participating remotely ]) ] In attendance: [ Insert the name of anyone in attendance who does not count towards the quorum for the Meeting (eg the company secretary, any legal advisers) ] Apologies: [ Insert...

Company number: [ insert number ] [ insert company name ] PLC Minutes of a meeting of the [ committee of the ] board of directors (the Meeting) of [ insert company name ] plc (the Company) Venue: [ insert place of meeting ] Date: [ insert day, month and year of meeting ] at [ insert time of meeting ] [ am OR pm ] Present [ Insert names of the director(s) physically present ] [ [ Insert names of any directors present by telephone as permitted by the Company’s articles of association ] (by telephone) ] [ [ Insert names of any directors present by other means permitted by the Company’s articles of association ] (by [ insert other means ]) ] In attendance [ [ Insert name of anyone in attendance, who does not count towards the quorum for the Meeting (eg the company secretary, any legal advisers) ] ] ...

STOP PRESS : Significant reforms to the UK prospectus regime came into force on 19 January 2026. New requirements for public offers of securities and for UK admissions to trading are now primarily contained in the Public Offers and Admissions to Trading Regulations 2024 (SI 2024/105) (the POATRs) and the FCA sourcebook, The Prospectus Rules: Admission to Trading on a Regulated Market (PRM). The UK Prospectus Regulation and the FCA Prospectus Regulation Rules have been revoked. The objective of the overhaul is to make capital raising simpler and to materially cut the instances in which a company must produce an FCA-approved prospectus for a subsequent share issue. For full details of the revisions, see Practice Note: UK prospectus regime reform. This Practice Note sets out the prospectus framework that applied before 19 January 2026...